Skip to main content

Systemic Sclerosis clinical trials at UCSF

2 research studies open to eligible people

Systemic sclerosis is a condition that leads to skin and organ hardening. UCSF is conducting research on the effectiveness of vixarelimab for lung issues related to this disease. Another study is focused on the impact and safety of a treatment called rapcabtagene autoleucel.

Showing trials for

Our lead scientists for Systemic Sclerosis research studies include .

Last updated: